Skip to main content
. 2007 Jul 25;104(31):12837–12842. doi: 10.1073/pnas.0703342104

Table 1.

Assessment of TCR BV (B variable) usage of vaccine-elicited CD8+ A2/NY-ESO-1157–165 multimer T cells and CD4+ DP4/NY-ESO-1157–170 T cells for patient 18

Clone CDR3β
A2 (CD8)
    2-5-C 1 CAS SPGQGPEQ YFG 2.7
    3-4-D 1 CAS SPGQGPEQ YFG 2.7
    5-5-B 1 CAS SPGQGPEQ YFG 2.7
    5-6-B 1 CAS SPGQGPEQ YFG 2.7
DP4 (CD4)
    2-C-10 (6) CAS SLVAAEGTQ YFG 2.5
    3-B-5 (6) CAS SLVAAEGTQ YFG 2.5
    5-B-8 (6) CAS SLVPDSAYEQ YFG 2.7
    8-H-12 (6) CAS SLVAAEGTQ YFG 2.5
HHS Vulnerability Disclosure